Stem Cell Therapy Market is expected to reach US$ 45.69 billion by 2033 | Major players - Mesoblast Ltd, Vericel Corporation., Novartis AG, Bluebird Bio, Inc.

Market Size and Growth:

The Global Stem Cell Therapy Market Size reached US$ 16.44 billion in 2024 and is expected to reach US$ 45.69 billion by 2033, growing at a CAGR of 12.7% during the forecast period 2025-2033. The Market is growing due to increasing prevalence of chronic diseases, rising demand for regenerative medicine, and advancements in stem cell research and technology. According to DataM Intelligence Report.

Get a Free Sample Research PDF: https://datamintelligence.com/download-sample/stem-cell-therapy-market?sz

The Stem Cell Therapy Market refers to the global industry focused on developing, manufacturing, and delivering treatments that use stem cells to repair, replace, or regenerate damaged tissues and organs. It includes regenerative medicine products, clinical applications, research advancements, and commercialization efforts aimed at treating chronic diseases, injuries, and degenerative conditions through innovative cell-based therapeutic approaches.

United States: Recent Developments of Stem Cell Therapy Market

✅ November 2025: BioRestorative Therapies reported third-quarter financial results, highlighting progress in its stem cell-based therapies for regenerative medicine, including advancements toward clinical applications for discogenic pain following earlier FDA clearance.​

✅ November 2025: Stanford researchers achieved a breakthrough by curing type 1 diabetes in mice using a gentle blood stem-cell and pancreatic islet transplant method, advancing potential human therapies.​

✅ October 2025: REPROCELL USA received funding from the Maryland Stem Cell Research Fund to develop GMP-grade capabilities for induced mesenchymal stem cells, enhancing manufacturing for stem cell therapies.​

Europe: Recent Developments of Stem Cell Therapy Market

✅ November 2025: The European Bone Marrow Transplantation (EBMT) released updated 2025 recommendations integrating advanced stem cell therapies like gene-modified cells and CAR-T for autoimmune diseases into clinical practice across Europe.​

✅ November 2025: Karolinska University Hospital in Sweden marked 50 years of leadership in allogeneic stem cell transplantation, including recent routine clinical use of CAR-T therapies.​

✅ October 2025: Industry updates noted ongoing harmonization of stem cell research protocols and EBMT guidelines promoting multidisciplinary approaches for transplantation and cellular therapies.​

Get Customization in the report as per your requirements: https://datamintelligence.com/customize/stem-cell-therapy-market?sz

Recent Regulatory Approvals in 2025:

✅ Zevaskyn (prademagene zamikeracel) - On 29 April 2025, the FDA approved Zevaskyn, an autologous cell‐sheet-based gene therapy for treatment of chronic wounds in adult and pediatric patients with Recessive Dystrophic Epidermolysis Bullosa (RDEB). This is described as the first and only autologous cell-based gene therapy for RDEB.

✅ Ryoncil (remestemcel‐L‐rknd) - Although approved in December 2024, its impact continues through 2025 as the first-ever mesenchymal stromal cell (MSC) therapy licensed by the FDA (for steroid-refractory acute GvHD in pediatric patients). This milestone underpins renewed interest in MSC‐based therapies in 2025.

✅ Overall according to a 2025 market report - there are now 12 MSC‐based therapies globally approved and marketed; but only Ryoncil is approved in the U.S. as of 2025.

✅ The broader field remains active: as of late 2025, over 1,670 clinical trials globally for MSC‐based therapies have been registered or are ongoing.

Major Players:

Key companies in the Stem Cell Therapy market include:

Mesoblast Ltd
Lineage Cell Therapeutics, Inc.
BlueRock Therapeutics LP
Orchard Therapeutics plc.
Vericel Corporation.
CRISPR Therapeutics AG
Fate Therapeutics, Inc.
Novartis AG
Bristol Myers Squibb (Juno Therapeutics, Inc.)
Bluebird Bio, Inc.
MEDIPOST Co., Ltd.
ANTEROGEN.CO.,LTD.
CORESTEMCHEMON Inc.
PHARMICELL Co., Ltd
JCR Pharmaceuticals Co., Ltd.

Segments Covered in the Stem Cell Therapy Market:

By Therapy Type: Autologous Stem Cell Therapy, Allogeneic Stem Cell Therapy.

By Cell Source: Adipose Tissue-Derived Mesenchymal Stem Cells, Bone Marrow-Derived Mesenchymal Stem Cells, Cord Blood/Embryonic Stem Cells, Others.

By Therapeutic Application: Musculoskeletal Disorders, Neurological Disorders, Autoimmune Diseases, Cardiovascular Diseases, Wounds & Surgeries, Inflammatory, Others.

Regional Analysis for Stem Cell Therapy Market:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Buy Now & Get 30% OFF - Grab 50% OFF on 2+ reports: https://www.datamintelligence.com/buy-now-page?report=stem-cell-therapy-market

Chapter Outline:

⏩ Market Overview: It contains five chapters, as well as information about the research scope, major manufacturers covered, market segments, Stem Cell Therapy market segments, study objectives, and years considered.

⏩ Market Landscape: The competition in the Global Stem Cell Therapy Market is evaluated here in terms of value, turnover, revenues, and market share by organization, as well as market rate, competitive landscape, and recent developments, transaction, growth, sale, and market shares of top companies.

⏩ Companies Profiles: The global Stem Cell Therapy market's leading players are studied based on sales, main products, gross profit margin, revenue, price, and growth production.

⏩ Market Outlook by Region: The report goes through gross margin, sales, income, supply, market share, CAGR, and market size by region in this segment. North America, Europe, Asia Pacific, Middle East & Africa, and South America are among the regions and countries studied in depth in this study.

⏩ Market Segments: It contains the deep research study which interprets how different end-user/application/type segments contribute to the Stem Cell Therapy Market.

⏩ Market Forecast: Production Side: In this part of the report, the authors have focused on production and production value forecast, key producers forecast, and production and production value forecast by type.

⏩ Research Findings: This section of the report showcases the findings and analysis of the report.

⏩ Conclusion: This portion of the report is the last section of the report where the conclusion of the research study is provided.

Unlimited Insights. One Subscription: https://www.datamintelligence.com/reports-subscription

Frequently asked questions:

➠ What is the global sales value, production value, consumption value, import and export of Stem Cell Therapy market?

➠ Who are the global key manufacturers of the Stem Cell Therapy Industry? How is their operating situation (capacity, production, sales, price, cost, gross, and revenue)?

➠ What are the Stem Cell Therapy market opportunities and threats faced by the vendors in the global Stem Cell Therapy Industry?

➠ Which application/end-user or product type may seek incremental growth prospects? What is the market share of each type and application?

➠ What focused approach and constraints are holding the Stem Cell Therapy market?

➠ What are the different sales, marketing, and distribution channels in the global industry?

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.